May 11, 2017 / 8:38 PM / 6 months ago

BRIEF-Cesca Therapeutics Q3 loss per share $0.21

May 11 (Reuters) - Cesca Therapeutics Inc:

* Cesca Therapeutics announces fiscal third quarter and nine month 2017 financial and operating results and provides corporate update

* Q3 revenue $3.3 million versus $2.8 million

* Q3 loss per share $0.21 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below